Zimmer Biomet Holdings, Inc. (ZBH) Q3 2026 earnings results
Zimmer Biomet Holdings, Inc. (ZBH) reported Q3 2026 results on Nov 4, 2026, 6:30:18 AM ET: adjusted EPS $1.90 vs. $1.88 expected (beat by 1.0%); revenue $2.06B vs. $2.04B expected (beat by 1.1%). Outlook: The company updated its full-year 2026 guidance for reported revenue change to 4.4% - 4.9% and adjusted diluted EPS to $8.50 - $8.60.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (adjusted, diluted) | $1.90 | $1.88 | Beat by 1.0% |
| Revenue | $2.06B | $2.04B | Beat by 1.1% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Nov 4, 2026, 6:30:18 AM ET. Nexqual published them 42 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 3.1% from $2.00B.
Stock reaction
The results came out before the market opened. ZBH closed at $110.15 on November 4, 2026, up 13.5% from its $97.06 close on November 3, 2026 before the results. Latest: $108.04 as of 11:53 AM ET, +11.3% since the pre-release close.
Questions and answers
Did Zimmer Biomet Holdings, Inc. beat earnings expectations?
Yes. Zimmer Biomet Holdings, Inc. reported adjusted EPS of $1.90 against an average analyst estimate of $1.88 (beat by 1.0%), and revenue of $2.06B against $2.04B expected (beat by 1.1%).
What were Zimmer Biomet Holdings, Inc.'s Q3 2026 earnings and revenue?
adjusted diluted EPS of $1.90 and revenue of $2.06B. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 3.1% from $2.00B.
When did Zimmer Biomet Holdings, Inc. report Q3 2026 earnings?
Nov 4, 2026, 6:30:18 AM ET, in an SEC 8-K filing (Item 2.02).
How did ZBH stock react to the earnings?
The results came out before the market opened. ZBH closed at $110.15 on November 4, 2026, up 13.5% from its $97.06 close on November 3, 2026 before the results. Latest: $108.04 as of 11:53 AM ET, +11.3% since the pre-release close.
What did Zimmer Biomet Holdings, Inc. say about its outlook?
The company updated its full-year 2026 guidance for reported revenue change to 4.4% - 4.9% and adjusted diluted EPS to $8.50 - $8.60.
More on ZBH
ZBH stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 4, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built November 10, 2026 at 16:53 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 10, 2026 at 16:53 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt